Game, set, match for factor VIII mismatch?
In this issue of Blood, Gunasekera et al provide evidence that the high rate of factor VIII (FVIII) inhibitors seen in black hemophilia A (HA) patients is not due to a mismatch between the structure of treatment products and FVIII genotypes common in blacks.
CENTERS FOR DISEASE CONTROL AND PREVENTION.
Connie H
CH
Miller
D001741:Black or African American / Q000235:genetics*; D057134:Antibodies, Neutralizing / Q000097:blood*; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000235:genetics*; D006467:Hemophilia A / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D008297:Male
D057134:Antibodies, Neutralizing; D005169:Factor VIII